Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J Med Allied Sci. 2020; 10(2): 104-109


To estimate the point prevalence of Rifampicin re-sistant tuberculosis in extra pulmonary tuberculosis patients’ as detected by CBNAAT in a district hospital and to analyze the data using logistic regression mathematical model

Santhosh Kumar Rajamani.




Abstract

The aim of this study was to estimate the point prevalence of Rifampicin resistant Mycobacteria causing tuberculosis of lymph node as detected by cartridge based nucleic acid amplification test (CBNAAT) and analyzed using logistic regression mathematical modeling. An observational cross-sectional study was carried out in the Department of Otorhinolaryngology from July 2019 to February 2020 in a tertiary healthcare setting. Rifampicin resistant Mycobacteria were identified; data tabulated and analyzed to find the point prevalence of Rifampicin resistant tuberculosis. A total of 37 patients who presented to the OPD were included in the study. Confirmation of the tuberculosis was done either by fine needle aspiration cytology (FNAC) or by direct biopsy. Demographic characteristics of the patients were analyzed. A logical regression mathematical model of Rifampicin resistance in the district was created. Correlation matrix was calculated using Jamovi software. Occurrence of Rifampicin resistance was dependent variable in logistic regression modeling. Levels VA and VB, posterior triangle group lymph nodes were most commonly involved. It was found that there is high prevalence 89.189% (p

Key words: Cervical lymph node tuberculosis, Multi-drug resistant tuberculosis, Nucleic acid amplification test, Rifampicin






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.